LSTA is expected to report earnings to fall -32% to -86 cents per share on February 29

A.I.dvisor
at Tickeron.com
02/28/24
Loading...
LSTA - Lisata Therapeutics
Lisata Therapeutics Earnings Graph
Q4'23
Est.
$-0.86
Q3'23
Beat
by $0.29
Q2'23
Beat
by $0.20
Q1'23
Beat
by $0.23
Q4'22
Beat
by $0.20
The last earnings report on September 30 showed earnings per share of -65 cents, beating the estimate of -94 cents. P/B Ratio (0.495) is normal, around the industry mean (27.786). P/E Ratio (0.000) is within average values for comparable stocks, (126.946). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.510). Dividend Yield (0.000) settles around the average of (0.031) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (408.973). With 18.08K shares outstanding, the current market capitalization sits at 26.21M.
View a ticker or compare two or three
LSTADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
110 Allen Road
Phone
+1 908 842-0100
Employees
25
Web
https://www.lisata.com